252 results
8-K
EX-99.1
MRK
Merck & Co Inc
24 Mar 11
Termination of a Material Definitive Agreement
12:00am
on Intervet/Schering-Plough’s broad and innovative portfolio going forward.
As a result of termination, both Merial and Intervet/Schering-Plough … and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing
access to healthcare
8-K
EX-99.1
MRK
Merck & Co Inc
30 Jan 19
Mary Ellen Coe Elected to Merck Board of Directors
1:44pm
. Coe’s strategic perspective and operational expertise at one of the world’s most innovative companies will be a significant asset to Merck,” said … , we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment
8-K
EX-99.3
MRK
Merck & Co Inc
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
will reverberate for decades.”
Glocer continued, “Rob Davis has shown himself to be an innovative leader with a deep understanding of Merck and our industry … and chief executive officer.
Under Ken’s leadership, Merck delivered innovative life-saving medicines and vaccines as well as long-term and sustainable
8-K
EX-99.1
MRK
Merck & Co Inc
8 Jul 10
Cost Associated with Exit or Disposal Activities
12:00am
the November 2009 merger of Merck and Schering-Plough. The consolidation plans support Merck’s strategic direction as a customer focused, innovative … and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our
8-K
EX-99.3
MRK
Merck & Co Inc
29 Apr 11
Merck Announces First Quarter 2011 Financial Results
12:00am
, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also … conditions; dependence on the effectiveness of Merck’s patents and other protections for innovative products; the risk of new and changing regulation
8-K
EX-99.1
4shsuc5lpqj3uw8y9twd
14 Oct 10
Merck Statement on Remicade and Simponi Arbitration
12:00am
8-K
EX-99.1
f0wr4od2vj390d
1 Dec 11
Merck Announces Retirement of Chairman and Former CEO Richard T. Clark
12:00am
8-K
EX-99.1
nqf5zred
11 Mar 10
Entry into a Material Definitive Agreement
12:00am
SC TO-T/A
EX-99
sf6ox8cz5apa9h93
21 Jan 15
Third party tender offer statement (amended)
12:00am
SC TO-T/A
EX-99
qg7fxe7
16 Jan 20
Third party tender offer statement (amended)
8:42am
8-K
EX-99.3
2a6kb4g8dxr241ymg33j
25 Oct 18
Results of Operations and Financial Condition
6:48am
8-K
EX-99.1
qs9v8p
2 Oct 14
Merck Completes Sale of Consumer Care Business to Bayer AG for $14.2 Billion
12:00am
8-K
EX-99.1
v99jy3m
15 Apr 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
ul2c9cw57y1
19 Feb 13
Results of Operations and Financial Condition
12:00am
SC TO-T/A
EX-99
i9qb4 c9ikv8qj
2 Apr 19
Third party tender offer statement (amended)
9:13am
8-K
EX-99.1
taijp0a
30 Nov 10
Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman
12:00am
8-K
EX-99.3
fpg2jd1s20d7jpj1dp
5 Feb 20
Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results
6:50am
8-K
EX-99.1
73a9tkc8wi5 0g
4 Nov 09
Merck and Schering-plough to Complete Merger Today
12:00am
8-K
EX-99.1
lbrwumfsu1r pa4
31 Jan 20
Dr. Christine Seidman and Kathy Warden Elected to Merck Board of Directors
5:15pm
SC TO-T
EX-99
2tjmnow3podw ep
5 Mar 19
Third party tender offer statement
9:45am